丽珠医药(01513.HK)8月21日耗资300万元回购7.21万股A股

Group 1 - The company, Lijun Pharmaceutical (01513.HK), announced a share buyback plan to repurchase 72,100 A-shares at a total cost of 3 million RMB [1] - The buyback will occur on August 21, 2025, with a price range of 41.15 to 41.90 RMB per share [1]